These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6511237)

  • 21. Phase II clinical trial of acivicin in advanced breast cancer: an Eastern Cooperative Oncology Group Study.
    Willson JK; Knuiman MW; Skeel RT; Wolter JM; Pandya KJ; Falkson G; Chang YC
    Cancer Treat Rep; 1986 Oct; 70(10):1237-8. PubMed ID: 3530452
    [No Abstract]   [Full Text] [Related]  

  • 22. A phase I study of pyrazofurin.
    Salem PA; Bodey GP; Burgess MA; Murphy WK; Freireich EJ
    Cancer; 1977 Dec; 40(6):2806-9. PubMed ID: 589556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II trial of acivicin in patients with advanced epithelial ovarian carcinoma. A Gynecologic Oncology Group Study.
    McGuire WP; Blessing JA; DiSaia PJ; Buchsbaum HJ
    Invest New Drugs; 1986; 4(1):49-52. PubMed ID: 3700040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The clinical phase I study of TNP-351. The TNP-351 Research Committee].
    Taguchi T; Niitani H; Furue H; Tsukagoshi S; Kanamaru R; Hasegawa K; Akazawa S; Yoneda S; Tominaga T; Sasaki T
    Gan To Kagaku Ryoho; 1995 Feb; 22(2):259-71. PubMed ID: 7857102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical phase I trial of marcellomycin with a single-dose schedule.
    Nicaise C; Rozencweig M; de Marneffe M; Crespeigne N; Dodion P; Piccart M; Sculier JP; Lenaz L; Kenis Y
    Eur J Cancer Clin Oncol; 1983 Apr; 19(4):449-54. PubMed ID: 6683182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase I trial of marcellomycin with a weekly dose schedule.
    Joss RA; Kaplan S; Goldhirsch A; Varini M; Brunner KW; Cavalli F
    Eur J Cancer Clin Oncol; 1983 Apr; 19(4):455-9. PubMed ID: 6683183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I trial and clinical pharmacology of elsamitrucin.
    Raber MN; Newman RA; Newman BM; Gaver RC; Schacter LP
    Cancer Res; 1992 Mar; 52(6):1406-10. PubMed ID: 1540949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I study of acivicin and cisplatin in non-small-cell lung cancer. A National Cancer Institute of Canada study.
    Maroun JA; Stewart DJ; Verma S; Evans WK; Eisenhauer E
    Am J Clin Oncol; 1990 Oct; 13(5):401-4. PubMed ID: 2171318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I and pharmacokinetic study of SM-5887, a new anthracycline derivative.
    Inoue K; Ogawa M; Horikoshi N; Mukaiyama T; Itoh Y; Imajoh K; Ozeki H; Nagamine D; Shinagawa K
    Invest New Drugs; 1989 Jul; 7(2-3):213-8. PubMed ID: 2793375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aclacinomycin A. Phase II evaluation in advanced soft tissue sarcoma.
    Pazdur R; Samson MK; Baker LH
    Am J Clin Oncol; 1987 Jun; 10(3):237-9. PubMed ID: 3473924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II trial of acivicin in advanced breast carcinoma: a Cancer and Leukemia Group B Study.
    Booth BW; Korzun AH; Weiss RB; Ellison RR; Budman D; Khojasteh A; Wood W
    Cancer Treat Rep; 1986 Oct; 70(10):1247-8. PubMed ID: 3530455
    [No Abstract]   [Full Text] [Related]  

  • 33. Aclacinomycin A. Phase II evaluation in bronchogenic squamous-cell carcinoma.
    Pazdur R; Samson MK; Baker LH
    Am J Clin Oncol; 1987 Jun; 10(3):234-6. PubMed ID: 3473923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I trial of 4-demethoxydaunorubicin with single i.v. doses.
    Kaplan S; Martini A; Varini M; Togni P; Cavalli F
    Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1303-6. PubMed ID: 6962779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized phase II study of acivicin and 4'deoxydoxorubicin in patients with hepatocellular carcinoma in an Eastern Cooperative Oncology Group study.
    Falkson G; Cnaan A; Simson IW; Dayal Y; Falkson H; Smith TJ; Haller DG
    Am J Clin Oncol; 1990 Dec; 13(6):510-5. PubMed ID: 2173394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase I evaluation of chlorozotocin (NSC-178248): weekly schedule.
    Moriconi WJ; Taylor S; Slavik M; Belt RJ; Haas CD; Hoogstraten B
    Invest New Drugs; 1985; 3(1):57-62. PubMed ID: 3157661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acivicin. An antitumor antibiotic.
    Poster DS; Bruno S; Penta J; Neil GL; McGovren JP
    Cancer Clin Trials; 1981; 4(3):327-30. PubMed ID: 7026076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase I trial of the anthrapyrazole CI-941: prospective evaluation of a pharmacokinetically guided dose-escalation.
    Foster BJ; Newell DR; Graham MA; Gumbrell LA; Jenns KE; Kaye SB; Calvert AH
    Eur J Cancer; 1992; 28(2-3):463-9. PubMed ID: 1591064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results of NCI-sponsored phase I trials with carboplatin.
    Foster BJ; Clagett-Carr K; Leyland-Jones B; Hoth D
    Cancer Treat Rev; 1985 Sep; 12 Suppl A():43-9. PubMed ID: 3910221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acivicin: a new glutamine antagonist in clinical trials.
    O'Dwyer PJ; Alonso MT; Leyland-Jones B
    J Clin Oncol; 1984 Sep; 2(9):1064-71. PubMed ID: 6470756
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.